Liver metastases: Contrast-enhanced ultrasound compared with computed tomography and magnetic resonance

World Journal of Gastroenterology

Volumn , Issue 29, 2014, Pages 9998-10007

  Cantisani, Vito ^a   Grazhdani, Hektor ^a   Fioravanti, Cristina ^a   Rosignuolo, Maria ^a   Calliada, Fabrizio ^b   Messineo, Daniela ^a   Bernieri, Maria Giulia ^a   Redler, Adriano ^a   Catalano, Carlo ^a   D'Ambrosio, Ferdinando ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

18F fluorodeoxyglucose positron emission tomography; Colorectal cancer; Colorectal liver metastases; Computed tomography; Contrast enhanced ultrasound; Intraoperative ultrasound; Magnetic resonance imaging; Ultrasound; Ultrasound contrast agent

Indexed keywords

ECHO CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; PERFLUBUTANE; PERFLUTREN; SONOVUE; CONTRAST MEDIUM; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

CANCER STAGING; COLORECTAL LIVER METASTASIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ECHOGRAPHY; HUMAN; IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); DIAGNOSTIC USE; LIVER NEOPLASMS; PREDICTIVE VALUE; PROGNOSIS; RADIOGRAPHY; SECONDARY; CANCER DIAGNOSIS; CANCER PATIENT; COMPUTED TOMOGRAPHY SCANNER; CONTRAST ENHANCEMENT; FOLLOW UP; HISTOPATHOLOGY; INTERMETHOD COMPARISON; LIVER METASTASIS; LIVER STRUCTURE; NUCLEAR MAGNETIC RESONANCE SCANNER; ULTRASOUND SCANNER;

CONTRAST MEDIA; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84905818048     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i29.9998     Document Type: Review

References (74)

1. Albrecht T, Hohmann J, Oldenburg A, Skrok J, Wolf KJ. Detection and characterisation of liver metastases. Eur Radiol 2004; 14 Suppl 8: P25-P33 [PMID: 15700330 DOI: 10.1007/s10406-004-0088-z]
2. Cosgrove DO, Bolondi L. Malignant liver disease. In: Cosgrove D, Meire H, Dewbury K, editors. Abdominal and general ultrasound. Edinburgh: Churchill Livingstone,1993: 271-293
3. Glover C, Douse P, Kane P, Karani J, Meire H, Mohammadtaghi S, Allen-Mersh TG. Accuracy of investigations for asymptomatic colorectal liver metastases. Dis Colon Rectum 2002; 45: 476-484 [PMID: 12006929 DOI: 10.1007/s10350-004-6224-y]
4. Xu LH, Cai SJ, Cai GX, Peng WJ. Imaging diagnosis of colorectal liver metastases. World J Gastroenterol 2011; 17: 4654-4659 [PMID: 22180707 DOI: 10.3748/wjg.v17.i42.4654]
5. Schima W, Kulinna C, Langenberger H, Ba-Ssalamah A. Liver metastases of colorectal cancer: US, CT or MR? Cancer Imaging 2005; 5 Spec No A: S149-S156 [PMID: 16361131 DOI: 10.1102/1470-7330.2005.0035]
6. Primrose JN. Surgery for colorectal liver metastases. Br J Cancer 2010; 102: 1313-1318 [PMID: 20424612 DOI: 10.1038/sj.bjc.6605659]
7. Ismaili N. Treatment of colorectal liver metastases. World J Surg Oncol 2011; 9: 154 [PMID: 22115124 DOI: 10.1186/1477-7819-9-154]
8. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995; 19: 59-71 [PMID: 7740812 DOI: 10.1007/BF00316981]
9. Bipat S, van Leeuwen MS, Comans EF, Pijl ME, Bossuyt PM, Zwinderman AH, Stoker J. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis - meta-analysis. Radiology 2005; 237: 123-131 [PMID: 16100087 DOI: 10.1148/radiol.2371042060]
10. Cosgrove D. Achieving optimal diagnostic yield through the use of real-time contrast enhanced ultrasonography (CEUS). Eur Radiol 2007; 17 (Suppl 6): F71-F72 [DOI: 10.1007/s10406-007-0238-1]
11. Lencioni R, Della Pina C, Crocetti L, Bozzi E, Cioni D. Clinical management of focal liver lesions: the key role of realtime contrast-enhanced US. Eur Radiol 2007; 17 Suppl 6: F73-F79 [PMID: 18376460 DOI: 10.1007/s10406-007-0231-8]
12. Solbiati L, Tonolini M, Cova L, Goldberg SN. The role of contrast-enhanced ultrasound in the detection of focal liver leasions. Eur Radiol 2001; 11 Suppl 3: E15-E26 [PMID: 11793049 DOI: 10.1007/PL00014125]
13. Karhunen PJ. Benign hepatic tumours and tumour like conditions in men. J Clin Pathol 1986; 39: 183-188 [PMID: 3950039]
14. Edmondson HA, Craig JR. Neoplasms of the liver. In: Schiff L, editor. Diseases of the liver. 8th ed. Philadelphia: Lippincott, 1987
15. Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsøe CP, Piscaglia F, Wilson SR, Barr RG, Chammas MC, Chaubal NG, Chen MH, Clevert DA, Correas JM, Ding H, Forsberg F, Fowlkes JB, Gibson RN, Goldberg BB, Lassau N, Leen EL, Mattrey RF, Moriyasu F, Solbiati L, Weskott HP, Xu HX. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver - update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med 2013; 34: 11-29 [PMID: 23129518 DOI: 10.1055/s-0032-1325499]
16. Furlan A, Marin D, Cabassa P, Taibbi A, Brunelli E, Agnello F, Lagalla R, Brancatelli G. Enhancement pattern of small hepatocellular carcinoma (HCC) at contrast-enhanced US (CEUS), MDCT, and MRI: intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for the Study of Liver Diseases (AASLD) guidelines. Eur J Radiol 2012; 81: 2099-2105 [PMID: 21906896 DOI: 10.1016/j.ejrad.2011.07.010]
17. Hohmann J, Albrecht T, Oldenburg A, Skrok J, Wolf KJ. Liver metastases in cancer: detection with contrast-enhanced ultrasonography. Abdom Imaging 2004; 29: 669-681 [PMID: 15185032 DOI: 10.1007/s00261-004-0175-6]
18. Konopke R, Bunk A, Kersting S. The role of contrast-enhanced ultrasound for focal liver lesion detection: an overview. Ultrasound Med Biol 2007; 33: 1515-1526 [PMID: 17618038 DOI: 10.1016/j.ultrasmedbio.2007.04.009]
19. Westwood M, Joore M, Grutters J, Redekop K, Armstrong N, Lee K, Gloy V, Raatz H, Misso K, Severens J, Kleijnen J. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis. Health Technol Assess 2013; 17: 1-243 [PMID: 23611316 DOI: 10.3310/hta17160]
20. Sica GT, Ji H, Ros PR. CT and MR imaging of hepatic metastases. AJR Am J Roentgenol 2000; 174: 691-698 [PMID: 10701611]
21. Ohlsson B, Nilsson J, Stenram U, Akerman M, Tranberg KG. Percutaneous fine-needle aspiration cytology in the diagnosis and management of liver tumours. Br J Surg 2002; 89: 757-762 [PMID: 12027987 DOI: 10.1046/j.1365-2168.2002.02111.x]
22. Valls C, Andía E, Sánchez A, Gumà A, Figueras J, Torras J, Serrano T. Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectability with helical CT. Radiology 2001; 218: 55-60 [PMID: 11152779 DOI: 10.1148/radiology.218.1.r01dc1155]
23. Portugaller HR, Stacher R, Komaz G, Aschauer M, Hausegger KA, Szolar DH. [The value of different spiral CT phases in the detection of liver metastases]. Rofo 2002; 174: 452-458 [PMID: 11960408 DOI: 10.1055/s-2002-25122]
24. Rappeport ED, Loft A. Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, computed tomography and positron emission tomography. Abdom Imaging 2007; 32: 624-634 [PMID: 17710359 DOI: 10.1007/s00261-007-9297-y]
25. Kim YK, Ko SW, Hwang SB, Kim CS, Yu HC. Detection and characterization of liver metastases: 16-slice multidetector computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging. Eur Radiol 2006; 16: 1337-1345 [PMID: 16453115 DOI: 10.1007/s00330-005-0140-y]
26. Scott DJ, Guthrie JA, Arnold P, Ward J, Atchley J, Wilson D, Robinson PJ. Dual phase helical CT versus portal venous phase CT for the detection of colorectal liver metastases: correlation with intra-operative sonography, surgical and pathological findings. Clin Radiol 2001; 56: 235-242 [PMID: 11247703 DOI: 10.1053/crad.2000.0668]
27. Bipat S, Niekel MC, Comans EF, Nio CY, Bemelman WA, Verhoef C, Stoker J. Imaging modalities for the staging of patients with colorectal cancer. Neth J Med 2012; 70: 26-34 [PMID: 22271811]
28. Bipat S, van Leeuwen MS, Ijzermans JN, Comans EF, Planting AS, Bossuyt PM, Greve JW, Stoker J. Evidence-base guideline on management of colorectal liver metastases in the Netherlands. Neth J Med 2007; 65: 5-14 [PMID: 17293634]
29. Coenegrachts K, De Geeter F, ter Beek L, Walgraeve N, Bipat S, Stoker J, Rigauts H. Comparison of MRI (including SS SE-EPI and SPIO-enhanced MRI) and FDG-PET/CT for the detection of colorectal liver metastases. Eur Radiol 2009; 19: 370-379 [PMID: 18795299 DOI: 10.1007/s00330-008-1163-y]
30. Coenegrachts K, Orlent H, ter Beek L, Haspeslagh M, Bipat S, Stoker J, Rigauts H. Improved focal liver lesion detection: comparison of single-shot spin-echo echo-planar and superparamagnetic iron oxide (SPIO)-enhanced MRI. J Magn Reson Imaging 2008; 27: 117-124 [PMID: 18050350 DOI: 10.1002/jmri.21247]
31. Niekel MC, Bipat S, Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 2010; 257: 674-684 [PMID: 20829538 DOI: 10.1148/radiol.10100729]
32. Kim HJ, Kim KW, Byun JH, Won HJ, Shin YM, Kim PN, Lee MS, Lee MG. Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients. AJR Am J Roentgenol 2006; 186: 1059-1066 [PMID: 16554579 DOI: 10.2214/AJR.04.1941]
33. Blyth S, Blakeborough A, Peterson M, Cameron IC, Majeed AW. Sensitivity of magnetic resonance imaging in the detection of colorectal liver metastases. Ann R Coll Surg Engl 2008; 90: 25-28 [PMID: 18201494 DOI: 10.1308/003588408X242303]
34. Jones WE, Thomas CR, Herman JM, Abdel-Wahab M, Azad N, Blackstock W, Das P, Goodman KA, Hong TS, Jabbour SK, Konski AA, Koong AC, Rodriguez-Bigas M, Small W, Zook J, Suh WW. ACR appropriateness criteria® resectable rectal cancer. Radiat Oncol 2012; 7: 161 [PMID: 23006527 DOI: 10.1186/1748-717X-7-161]
35. van Erkel AR, Pijl ME, van den Berg-Huysmans AA, Wasser MN, van de Velde CJ, Bloem JL. Hepatic metastases in patients with colorectal cancer: relationship between size of metastases, standard of reference, and detection rates. Radiology 2002; 224: 404-409 [PMID: 12147835 DOI: 10.1148/radiol.2242011322]
36. Suh WW, Blackstock AW, Herman J, Konski AA, Mohiuddin M, Poggi MM, Regine WF, Cosman BC, Saltz L, Johnstone PA. ACR Appropriateness Criteria on resectable rectal cancer: expert panel on radiation oncology - rectal/anal cancer. Int J Radiat Oncol Biol Phys 2008; 70: 1427-1430 [PMID: 18374227 DOI: 10.1016/j.ijrobp.2007.09.029]
37. Ward J, Robinson PJ, Guthrie JA, Downing S, Wilson D, Lodge JP, Prasad KR, Toogood GJ, Wyatt JI. Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology 2005; 237: 170-180 [PMID: 16126930 DOI: 10.1148/radiol.2371041444]
38. Kim MJ, Kim JH, Chung JJ, Park MS, Lim JS, Oh YT. Focal hepatic lesions: detection and characterization with combination gadolinium- and superparamagnetic iron oxideenhanced MR imaging. Radiology 2003; 228: 719-726 [PMID: 12881583 DOI: 10.1148/radiol.2283020735]
39. del Frate C, Bazzocchi M, Mortele KJ, Zuiani C, Londero V, Como G, Zanardi R, Ros PR. Detection of liver metastases: comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MR imaging examinations. Radiology 2002; 225: 766-772 [PMID: 12461259 DOI: 10.1148/radiol.2253011854]
40. Soyer P, Poccard M, Boudiaf M, Abitbol M, Hamzi L, Panis Y, Valleur P, Rymer R. Detection of hypovascular hepatic metastases at triple-phase helical CT: sensitivity of phases and comparison with surgical and histopathologic findings. Radiology 2004; 231: 413-420 [PMID: 15044747 DOI: 10.1148/radiol.2312021639]
41. Kim YK, Lee JM, Kim CS, Chung GH, Kim CY, Kim IH. Detection of liver metastases: gadobenate dimeglumine-enhanced three-dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced MR imaging. Eur Radiol 2005; 15: 220-228 [PMID: 15624108 DOI: 10.1007/s00330-004-2570-3]
42. Nasu K, Kuroki Y, Nawano S, Kuroki S, Tsukamoto T, Yamamoto S, Motoori K, Ueda T. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 2006; 239: 122-130 [PMID: 16493012 DOI: 10.1148/radiol.2383041384]
43. Szurowska E, Nowicki TK, Izycka-Swieszewska E, Zadrozny D, Markiet K, Studniarek M. Predictive value of apparent diffusion coefficient in evaluation of colorectal carcinoma hepatic metastases' response to radiofrequency ablation. J Magn Reson Imaging 2013; 38: 1027-1032 [PMID: 23526807 DOI: 10.1002/jmri.24089]
44. Lambregts DM, Maas M, Cappendijk VC, Prompers LM, Mottaghy FM, Beets GL, Beets-Tan RG. Whole-body diffusion-weighted magnetic resonance imaging: current evidence in oncology and potential role in colorectal cancer staging. Eur J Cancer 2011; 47: 2107-2116 [PMID: 21664810 DOI: 10.1016/j.ejca.2011.05.013]
45. Frankel TL, Gian RK, Jarnagin WR. Preoperative imaging for hepatic resection of colorectal cancer metastasis. J Gastrointest Oncol 2012; 3: 11-18 [PMID: 22811865 DOI: 10.3978/j.issn.2078-6891.2012.002]
46. Mainenti PP, Mancini M, Mainolfi C, Camera L, Maurea S, Manchia A, Tanga M, Persico F, Addeo P, D'Antonio D, Speranza A, Bucci L, Persico G, Pace L, Salvatore M. Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents. Abdom Imaging 2010; 35: 511-521 [PMID: 19562412 DOI: 10.1007/s00261-009-9555-2]
47. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 2002; 224: 748-756 [PMID: 12202709 DOI: 10.1148/radiol.2243011362]
48. Seo HJ, Kim MJ, Lee JD, Chung WS, Kim YE. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases. Invest Radiol 2011; 46: 548-555 [PMID: 21577131 DOI: 10.1097/RLI.0b013e31821a2163]
49. Dawson P, Cosgrove D, Grainger R. Textbook of contrast media. Oxford: ISIS Medical Media, 1999
50. Piscaglia F, Lencioni R, Sagrini E, Pina CD, Cioni D, Vidili G, Bolondi L. Characterization of focal liver lesions with contrast-enhanced ultrasound. Ultrasound Med Biol 2010; 36: 531-550 [PMID: 20350680 DOI: 10.1016/j.ultrasmedbio.2010.01.004]
51. Albrecht T. Detection and characterisation of liver metastases. In: Lencioni R, editor. Enhancing the role of ultrasound with contrast agents. Pisa: Springer-Verlag Italia, 2006: 53-67
52. Larsen LP. Role of contrast enhanced ultrasonography in the assessment of hepatic metastases: A review. World J Hepatol 2010; 2: 8-15 [PMID: 21160951 DOI: 10.4254/wjh.v2.i1.8]
53. Kreft B, Pauleit D, Bachmann R, Conrad R, Krämer A, Schild HH. [Incidence and significance of small focal liver lesions in MRI]. Rofo 2001; 173: 424-429 [PMID: 11414150 DOI: 10.1055/s-2001-13340]
54. Jones EC, Chezmar JL, Nelson RC, Bernardino ME. The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT. AJR Am J Roentgenol 1992; 158: 535-539 [PMID: 1738990 DOI: 10.2214/ajr.158.3.1738990]
55. Schwartz LH, Gandras EJ, Colangelo SM, Ercolani MC, Panicek DM. Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 1999; 210: 71-74 [PMID: 9885589 DOI: 10.1148/radiology.210.1.r99ja0371]
56. Cosgrove D, Blomley M. Liver tumors: evaluation with contrast-enhanced ultrasound. Abdom Imaging 2004; 29: 446-454 [PMID: 14716451 DOI: 10.1007/s00261-003-0126-7]
57. Konopke R, Kersting S, Bergert H, Bloomenthal A, Gastmeier J, Saeger HD, Bunk A. Contrast-enhanced ultrasonography to detect liver metastases: a prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy. Int J Colorectal Dis 2007; 22: 201-207 [PMID: 16733650 DOI: 10.1007/s00384-006-0134-5]
58. Bernatik T, Strobel D, Hahn EG, Becker D. Detection of liver metastases: comparison of contrast-enhanced wide-band harmonic imaging with conventional ultrasonography. J Ultrasound Med 2001; 20: 509-515 [PMID: 11345108]
59. Cantisani V, Ricci P, Erturk M, Pagliara E, Drudi F, Calliada F, Mortele K, D'Ambrosio U, Marigliano C, Catalano C, Marin D, Di Seri M, Longo F, Passariello R. Detection of hepatic metastases from colorectal cancer: prospective evaluation of gray scale US versus SonoVue® low mechanical index real time-enhanced US as compared with multidetector-CT or Gd-BOPTA-MRI. Ultraschall Med 2010; 31: 500-505 [PMID: 20408122 DOI: 10.1055/s-0028-1109751]
60. Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, Sano K, Sano M, Kato S, Kitamura T, Fatima Z, Fukushima K, Iino H, Mori Y, Fujii H, Araki T. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging 2011; 34: 326-335 [PMID: 21780227 DOI: 10.1002/jmri.22613]
61. Cabassa P, Bipat S, Longaretti L, Morone M, Maroldi R. Liver metastases: Sulphur hexafluoride-enhanced ultrasonography for lesion detection: a systematic review. Ultrasound Med Biol 2010; 36: 1561-1567 [PMID: 20800958 DOI: 10.1016/j.ultrasmedbio.2010.06.004]
62. Itabashi T, Sasaki A, Otsuka K, Kimura T, Nitta H, Wakabayashi G. Potential value of sonazoid-enhanced intraoperative laparoscopic ultrasonography for liver assessment during laparoscopy-assisted colectomy. Surg Today 2014; 44: 696-701 [PMID: 23670037 DOI: 10.1007/s00595-013-0607-4]
63. Leoni S, Piscaglia F, Golfieri R, Camaggi V, Vidili G, Pini P, Bolondi L. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. Am J Gastroenterol 2010; 105: 599-609 [PMID: 19935786 DOI: 10.1038/ajg.2009.654]
64. Bolondi L. The appropriate allocation of CEUS in the diagnostic algorithm of liver lesions: a debated issue. Ultrasound Med Biol 2013; 39: 183-185 [PMID: 23140590 DOI: 10.1016/j.ultrasmedbio.2012.10.001]
65. Larsen LP, Rosenkilde M, Christensen H, Bang N, Bolvig L, Christiansen T, Laurberg S. Can contrast-enhanced ultrasonography replace multidetector-computed tomography in the detection of liver metastases from colorectal cancer? Eur J Radiol 2009; 69: 308-313 [PMID: 18068925]
66. Piscaglia F, Corradi F, Mancini M, Giangregorio F, Tamberi S, Ugolini G, Cola B, Bazzocchi A, Righini R, Pini P, Fornari F, Bolondi L. Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer. BMC Cancer 2007; 7: 171 [PMID: 17767722 DOI: 10.1186/1471-2407-7-171]
67. Larsen LP, Rosenkilde M, Christensen H, Bang N, Bolvig L, Christiansen T, Laurberg S. The value of contrast enhanced ultrasonography in detection of liver metastases from colorectal cancer: a prospective double-blinded study. Eur J Radiol 2007; 62: 302-307 [PMID: 17194561 DOI: 10.1016/j.ejrad.2006.11.033]
68. Janica JR, Lebkowska U, Ustymowicz A, Augustynowicz A, Kamocki Z, Werel D, Polaków J, Kedra B, Pepinski W. Contrast-enhanced ultrasonography in diagnosing liver metastases. Med Sci Monit 2007; 13 Suppl 1: 111-115 [PMID: 17507895]
69. Dietrich CF, Kratzer W, Strobe D, Danse E, Fessl R, Bunk A, Vossas U, Hauenstein K, Koch W, Blank W, Oudkerk M, Hahn D, Greis C. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol 2006; 12: 1699-1705 [PMID: 16586537 DOI: 10.3748/wjg.v12.i11.1699]
70. Quaia E, D'Onofrio M, Palumbo A, Rossi S, Bruni S, Cova M. Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol 2006; 16: 1599-1609 [PMID: 16552507 DOI: 10.1007/s00330-006-0192-7]
71. Konopke R, Kersting S, Saeger HD, Bunk A. [Detection of liver lesions by contrast-enhanced ultrasound - comparison to intraoperative findings]. Ultraschall Med 2005; 26: 107-113 [PMID: 15852173 DOI: 10.1055/s-2005-858095]
72. Oldenburg A, Hohmann J, Foert E, Skrok J, Hoffmann CW, Frericks B, Wolf KJ, Albrecht T. Detection of hepatic metastases with low MI real time contrast enhanced sonography and SonoVue. Ultraschall Med 2005; 26: 277-284 [PMID: 16123921 DOI: 10.1055/s-2005-858526]
73. Albrecht T, Oldenburg A, Hohmann J, Skrok J, Hoffmann CW, Schettler S, Wolf KJ. Imaging of liver metastases with contrast-specific low-MI real-time ultrasound and SonoVue. Eur Radiol 2003; 13 Suppl 3: N79-N86 [PMID: 15015886 DOI: 10.1007/s00330-003-0012-2]
74. Albrecht T, Hoffmann CW, Schmitz SA, Schettler S, Overberg A, Germer CT, Wolf KJ. Phase-inversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastases. AJR Am J Roentgenol 2001; 176: 1191-1198 [PMID: 11312180 DOI: 10.2214/ajr.176.5.1761191]